ATM-the gene at the moment in non-small cell lung cancer
- PMID: 38601449
- PMCID: PMC11002499
- DOI: 10.21037/tlcr-23-853
ATM-the gene at the moment in non-small cell lung cancer
Keywords: Ataxia-telangiectasia mutated (ATM); lung adenocarcinoma (LUAD); non-small cell lung cancer (NSCLC).
Conflict of interest statement
Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at https://tlcr.amegroups.com/article/view/10.21037/tlcr-23-853/coif). J.Y.Y. is a recipient of quality improvement grants from AstraZeneca, Bayer, Amgen, and Pfizer; he also received consulting fees from Roche and honoraria from Amgen, Merck and Canadian Society for Medical Laboratory Science. The other author has no conflicts of interest to declare.
Comment on
-
Clinicopathologic, Genomic, and Immunophenotypic Landscape of ATM Mutations in Non-Small Cell Lung Cancer.Clin Cancer Res. 2023 Jul 5;29(13):2540-2550. doi: 10.1158/1078-0432.CCR-22-3413. Clin Cancer Res. 2023. PMID: 37097610 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous